Advanced pharmaceutical manufacturing through automation

Digital transformation addresses the fundamental inefficiencies that limit pharmaceutical manufacturing performance. Industry data shows that approximately 30% of staff time is consumed by documentation-related activities, while manual processes result in documentation accuracy of only 91%1. A single biotech batch can involve between 5,000 and 45,000 manual entries,1 creating substantial opportunities for errors and delays. 
 
Digital platforms provide end-to-end visibility across manufacturing operations, enabling data-driven decision making and continuous improvement. Automated workflows reduce the regulatory burden by ensuring complete traceability, maintaining secure audit trails and expediting regulatory submissions. These capabilities support faster time to market while reducing the risk of compliance failures that can result in costly penalties and reputational damage.

Pharmaceutical quality management systems provide structured framework that helps companies to maintain compliance with diverse regulatory requirements across multiple jurisdictions. These platforms centralize quality processes including change control, deviation management, complaint handling, CAPA and document management, aiming at consistent application of procedures across all manufacturing sites. 
 
Integration with manufacturing execution systems, laboratory systems and building management platforms creates a holistic quality environment where factors affecting product quality are monitored and documented. This comprehensive approach helps pharmaceutical companies to demonstrate compliance during regulatory inspections, accelerate regulatory approvals for new products and maintain the continuous state of readiness required in highly regulated environments. 

Batch review in manual environments can take 40 to 50 hours, representing approximately 30% of the total cycle time.2 Automation mitigates this by implementing review-by-exception workflows that flag only deviations requiring attention, reducing review time. Electronic batch records reduce the need to clarify missing information and reconcile manual entries, while automated data collection helps provide comprehensive documentation at every manufacturing step. Integration with quality management systems streamlines approval workflows and maintains continuous audit trails, helping teams release batches faster without compromising regulatory compliance.

Tech transfers involve moving products and manufacturing knowledge between facilities, requiring equipment qualification, method validation and batch testing at each site. Poor execution can lead to costly delays, regulatory issues and lost revenue.

Automation helps by maintaining consistent electronic records and standard operating procedures that transfer between locations. Unified platforms reduce the need to reconcile different batch record formats and data systems when working with contract manufacturing organizations. Digital twins and virtual engineering capabilities allow process validation before physical implementation, while comprehensive data capture supports faster regulatory submissions and reduces duplicative testing requirements.

Sources:

https://process.honeywell.com/content/dam/process/en/documents/gated/3%20STEPS%20TO%20DIGITAL%20TRANSFORMATION.pdf

https://process.honeywell.com/content/dam/process/en/campaigns/hps/modular-automation--the-plug-and-produce-opportunity/documents/hon-ia-hps-3341532-whitepaper-03-07.pdf